Chong Kun Dang Pharmaceutical Corp. (185750.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩61,300 (-0.97%) as of
Key statistics
- Market cap
- 807.69B
- Forward P/E
- 11.05
- Dividend yield
- 0.81%
- 52-week range
- 61,000.00 – 98,100.00
- Beta
- 0.24
- Revenue (TTM)
- 1.78T
- Profit margin
- 4.46%
- Analyst target
- ₩102,857.14
- Volume
- 33.71k
About Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 2,170
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.